"Before the operation, I would look at someone and all I could see for their face was jell

y," says Jonathan Wyatt "Now, I can see peoples faces." The 65-year-old is one of six people in the world to receive gene therapy for a【C1】______type of inherited eye disease【C2】______choroideremia(an eye disease). The first published【C3】______of the trial, released today, suggest that【C4】______peoples genes can stop the disease from causing blindness—and【C5】______sight in those whose vision has become【C6】______. Choroideremia is caused by【C7】______in the CHM gene. In those who have the disease, a【C8】______of REP-1 means that cells in the eyes stop working and slowly begin to【C9】______causing blindness. Enter gene therapy, which uses a virus to insert a【C10】______copy of a gene into cells with a gene defect and could【C11】______be used to treat many genetic conditions. Robert MacLaren of the University of Oxford and his colleagues decided to see if it could【C12】______choroideremia. Starting two years ago with Wyatt, they【C13】______a virus carrying a corrective copy of the CHM gene into the eyes of people with choroideremia. Today the team【C14】______that of the six people who received the treatment six months【C15】______or longer, all have described【C16】______in their vision. Still, the long-lasting effects of the treatment remain【C17】______Wyatt had the treatment first, so can【C18】______that the benefits seem to last two years,【C19】______hes just one case. The treatment also cant replace cells that have been【C20】______destroyed.

【C1】

A．common

B．ambiguous

C．rare

D．simple